Anti-CFH Monoclonal Antibody GT103 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: GT 103, GT-103, GT103

Filter by location:

Buffalo, New York1 trial

GT103 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic STK11 Mutant Non-Small Cell Lung Cancer

Roswell Park Cancer Institute

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.